JOEL R. LANIK

Profile

First Name

: JOEL

Middle Name

: R.

Last Name

: LANIK

Related Companies

Titles

Company Name

Related People

DIRECTOR

J. TOBIN GEATZ, MARC KLEE, RICHARD T. MACLEAN, JEFFERY S. REINICHE, CHRISTOPHER SLEAT

DIRECTOR

CONCLUSIVE MARKETING

ANDREW BACH, WILLIAM J. BRENNAN, DONALD CLIFFORD, JOHN A. HILL, DONALD M. JOHNSTON, DONAL LEYRER, RICHARD T. MACLEAN, LISA MCALLISTER, JAMES MEDIATE, PHIL PFEFFER, JOHN S. RICHARDSON, JAN RIVENBARK, CHARLES W. STRYKER

DIRECTOR

CONCLUSIVE MARKETING, INC.

ANDREW BACH, WILLIAM J. BRENNAN, DONALD CLIFFORD, JOHN A. HILL, DONALD M. JOHNSTON, DONAL LEYRER, RICHARD T. MACLEAN, LISA MCALLISTER, JAMES MEDIATE, PHIL PFEFFER, JOHN S. RICHARDSON, JAN RIVENBARK, CHARLES W. STRYKER

DIRECTOR

CONCLUSIVE ANALYTICS, INC.

ANDREW BACH, WILLIAM J. BRENNAN, DONALD CLIFFORD, JOHN A. HILL, DONALD M. JOHNSTON, DONAL LEYRER, RICHARD T. MACLEAN, LISA MCALLISTER, JAMES MEDIATE, PHIL PFEFFER, JOHN S. RICHARDSON, JAN RIVENBARK, CHARLES W. STRYKER

EXECUTIVE OFFICER, DIRECTOR

INCLINIX-PMG HOLDINGS, INC.

J. TOBIN GEATZ, JOEL R LANIK, RICHARD T MACLEAN, RICHARD T. MACLEAN, JEFFREY S REINICHE

EXECUTIVE OFFICER, DIRECTOR

FRONTIER FUND VI-B, L.P.

ANDREW D. LINDNER, RICHARD T. MACLEAN, JAMES MICHAEL RAMICH

EXECUTIVE OFFICER, DIRECTOR

FRONTIER FUND VI-A, L.P.

ANDREW D. LINDNER, RICHARD T. MACLEAN, JAMES MICHAEL RAMICH

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-01-21

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-01-21

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2014-05-22

D

OTHER

DECLINE TO DISCLOSE

Equity

2013-09-27

D/A

OTHER

DECLINE TO DISCLOSE

Equity

2011-07-14

D

OTHER

DECLINE TO DISCLOSE

Equity

2011-07-14

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity

2011-01-27

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2010-09-24

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity

2010-08-12